Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | Healthcare | 422,193.0 | $56.9M | 7.91% | -118K | -21.8% | $134.85 | -15.7% |
| 2 | COGT | COGENT BIOSCIENCES INC | Healthcare | 1,245,254.0 | $44.2M | 6.14% | +430K | +52.8% | $35.52 | -9.4% |
| 3 | URGN | UROGEN PHARMA LTD | Healthcare | 1,738,821.0 | $40.7M | 5.66% | +162K | +10.2% | $23.42 | +23.6% |
| 4 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 2,427,118.0 | $39.2M | 5.44% | +1.1M | +78.0% | $16.15 | +65.6% |
| 5 | CELC | CELCUITY INC | Healthcare | 375,132.0 | $37.4M | 5.20% | +286K | +323.0% | $99.74 | +35.8% |
| 6 | NUVL | NUVALENT INC | Healthcare | 311,430.0 | $31.3M | 4.35% | -61K | -16.4% | $100.59 | +0.6% |
| 7 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 750,136.0 | $30.9M | 4.29% | +75K | +11.1% | $41.21 | +106.7% |
| 8 | KOD | KODIAK SCIENCES INC | Healthcare | 1,023,122.0 | $28.6M | 3.97% | +23K | +2.3% | $27.96 | +31.1% |
| 9 | — | PRAXIS PRECISION MEDICINES I | — | 82,465.0 | $24.3M | 3.38% | +31K | +61.0% | $294.74 | — |
| 10 | IMNM | IMMUNOME INC | Healthcare | 1,126,210.0 | $24.2M | 3.36% | NEW | — | $21.48 | -4.8% |
| 11 | GUTS | FRACTYL HEALTH INC | Healthcare | 9,840,041.0 | $21.6M | 3.01% | -760K | -7.2% | $2.20 | -62.3% |
| 12 | — CALL | UNIQURE NV | — | 720,800.0 | $17.2M | 2.40% | NEW | — | $23.93 | — |
| 13 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 1,029,066.0 | $16.1M | 2.24% | +334K | +48.1% | $15.68 | +15.6% |
| 14 | VCYT | VERACYTE INC | Healthcare | 357,558.0 | $15.1M | 2.09% | +122K | +51.6% | $42.10 | -6.7% |
| 15 | CGON | CG ONCOLOGY INC | Healthcare | 361,158.0 | $15.0M | 2.08% | -277K | -43.4% | $41.52 | +56.9% |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 135,950.0 | $14.6M | 2.02% | -234K | -63.3% | $107.04 | -14.8% |
| 17 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 642,899.0 | $13.5M | 1.88% | +179K | +38.6% | $21.01 | -4.0% |
| 18 | BIIB | BIOGEN INC | Healthcare | 75,412.0 | $13.3M | 1.84% | -5K | -6.2% | $175.99 | +8.1% |
| 19 | INSM | INSMED INC | Healthcare | 71,256.0 | $12.4M | 1.72% | -135K | -65.5% | $174.04 | -39.7% |
| 20 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 458,203.0 | $11.5M | 1.59% | +317K | +224.4% | $25.01 | +58.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%